HPV vaccine
Coverage of HPV vaccine in the Nexus archive.
- Preserving vaccine progress depends strong, fact-based public policy
The article emphasizes the importance of strong, fact-based public health policies to maintain vaccine accessibility and availability, particularly highlighting the role of state-level advocacy in Louisiana. It underscores vaccines as a major public health achievement and calls for continued community engagement to preserve progress against preventable diseases.
- Inside Health
The article discusses whether the success of the HPV vaccine could lead to a reduction in cervical screening. It raises the question of if decreased cervical cancer risk due to vaccination might affect screening recommendations.
- Abortion medication, HPV vaccine laws take effect Wednesday in three states
New laws in Iowa, Mississippi, and Tennessee restrict access to abortion medications and limit minors' access to sexual and reproductive healthcare, including the HPV vaccine. A federal lawsuit challenges FDA rules allowing mifepristone to be dispensed via telehealth, with nationwide implications.
- Abortion medication, HPV vaccine laws take effect Wednesday in three states
New laws in Iowa, Mississippi, and Tennessee restrict access to abortion medications and HPV vaccines for minors, effective July 1. The laws require in-person dispensing of abortion pills and prohibit minors under 18 from consenting to STD-related vaccinations in Iowa. A federal lawsuit challenges FDA rules allowing telehealth dispensing of mifepristone, which could impact nationwide access.
- Abortion medication, HPV vaccine laws take effect today in three states
New laws in Iowa, Mississippi, and Tennessee restrict access to abortion medications like mifepristone and misoprostol and limit minors' access to the HPV vaccine. A federal lawsuit challenges FDA rules allowing telehealth dispensing of mifepristone, with nationwide implications.
- For the first time ever, no young women in England died of cervical cancer. In the U.S., RFK Jr.’s vaccine skepticism stalls HPV progress
A study in England found no cervical cancer deaths among women aged 20-24 between 2020-2024, attributed to high HPV vaccination rates (88-90% coverage). In the U.S., RFK Jr.'s vaccine skepticism is slowing HPV vaccination progress.
- Cervical cancer deaths fall to zero in young women given vaccine
A new study finds that hundreds of lives have been saved since school-age girls were offered the HPV vaccine in 2008, with cervical cancer deaths falling to zero in young women who received the vaccine.
- Cervical cancer deaths fall to zero in young women given vaccine
A new study reports that cervical cancer deaths have fallen to zero in young women who received the HPV vaccine. The study attributes hundreds of saved lives to the vaccine being offered to school-age girls since 2008.
- HPV jab could protect men from mouth, throat and penile cancers, major study finds
A major study suggests the HPV vaccine could protect men from mouth, throat, and penile cancers. The findings highlight the potential of the jab in preventing these cancers, which are increasingly linked to HPV infection.